DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

Manufacturer

Sandoz Inc.

NDC

00781232901

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

9/17/2025

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021303

On Market Since

4/2/2009

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.9%

3Y

-26.8%

5Y

-32.1%

All

-84.8%